Cencora Inc
NYSE:COR
EV/EBIT
Enterprise Value to EBIT
Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.
Market Cap | EV/EBIT | ||||
---|---|---|---|---|---|
US |
Cencora Inc
NYSE:COR
|
44.3B USD | 16.5 | ||
US |
Mckesson Corp
NYSE:MCK
|
73.4B USD | 18.9 | ||
US |
Amerisourcebergen Corp
NYSE:ABC
|
35.4B USD | 15.2 | ||
US |
Cardinal Health Inc
NYSE:CAH
|
24.2B USD | 12 | ||
US |
Henry Schein Inc
NASDAQ:HSIC
|
9.6B USD | 17.7 | ||
KR |
C
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 61.9 | |
CN |
Sinopharm Group Co Ltd
HKEX:1099
|
68.5B HKD | 2.1 | ||
IT |
Amplifon SpA
MIL:AMP
|
7.8B EUR | 31.5 | ||
CN |
Huadong Medicine Co Ltd
SZSE:000963
|
58.2B CNY | 15.1 | ||
CN |
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
52.6B CNY | 8.5 | ||
DE |
M
|
McKesson Europe AG
XHAM:CLS1
|
5B EUR | 19.2 |
EV/EBIT Forward Multiples
Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.